Ovulation inhibition with nafarelin acetate nasal administration for six months
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 32 (6) , 531-551
- https://doi.org/10.1016/s0010-7824(85)80001-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Peptide contraception in women: Inhibition of ovulation by chronic intranasal LRH agonist therapyContraception, 1985
- The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived from treated and untreated conception cyclesFertility and Sterility, 1982
- Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?Contraception, 1981
- INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENTThe Lancet, 1979
- Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonistContraception, 1979
- Single luteal phase serum progesterone assay as an indicator of ovulationAmerican Journal of Obstetrics and Gynecology, 1972
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972
- Serum gonadotropin and steroid patterns during the normal menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1971
- Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analysesBiochemical and Biophysical Research Communications, 1971
- Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequenceBiochemical and Biophysical Research Communications, 1971